Combined MR quantitative susceptibility mapping and multi-shell diffusion in Parkinson's disease

Oscar Andersson Forsman1, Henrik Sjöström1,2, Per Svenningsson1,2,3

  • 1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Summary

Quantitative susceptibility mapping (QSM) and neurite orientation dispersion and density imaging (NODDI) combined show promise as biomarkers for Parkinson's disease (PD) diagnosis. This imaging marker combination improved the differentiation of PD patients from healthy controls.